-
Archives
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- November 2015
- September 2015
- July 2015
- June 2015
- February 2015
- October 2014
- August 2014
- March 2014
- January 2014
- September 2013
- August 2013
- June 2013
- May 2013
- March 2013
- February 2013
- December 2012
- November 2012
- August 2012
- July 2012
- June 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- April 2011
- March 2011
- February 2011
- January 2011
-
Meta
Author Archives: Jessica
New Clinical Study Evaluates First Drug to Show Improvement in Subtype of Autism
Researchers at the Seaver Autism Center, led by Dr. Alex Kolevzon, have begun a clinical trial to evaluate insulin-like growth factor in children who have SHANK3 deficiency, a known cause of autism spectrum disorder. Click here to read the press … Continue reading
Posted in News
Comments Off on New Clinical Study Evaluates First Drug to Show Improvement in Subtype of Autism
Prevalence of ASD has risen to 1 in 88
The Centers for Disease Control and Prevention report that the prevalence of autism spectrum disorders has increased to 1 in 88 children. Click here to learn more.
Posted in News
Comments Off on Prevalence of ASD has risen to 1 in 88
Parents, We Need your Input
Help us Learn More about Early Autism Diagnoses The Seaver Autism Center at the Mount Sinai School of Medicine is collaborating with Columbia University as well as the Autism Science Foundation to better identify barriers to early diagnosis of autism … Continue reading
Posted in News
Comments Off on Parents, We Need your Input
“Research Webinar: Bench to Bedside at Mt. Sinai” hosted by the Phelan-McDermid Syndrome Foundation
“Please join the Phelan-McDermid Syndrome Foundation for a conversation with Joseph Buxbaum, PhD, and Alex Kolevzon, MD. We’ll discuss the basic science and clinical research projects that are underway at the Seaver Autism Center at Mt. Sinai School of Medicine … Continue reading
Posted in News
Comments Off on “Research Webinar: Bench to Bedside at Mt. Sinai” hosted by the Phelan-McDermid Syndrome Foundation
Dr. Joseph Buxbaum presents the first rat model for Shank3
At the recent Society for Neuroscience meeting in Washington, D.C., Dr. Joseph Buxbaum presented the first rat model lacking a copy of the Shank3 gene. This is a very important step in Shank3 research, as rat models provide benefits that … Continue reading
Posted in News
Comments Off on Dr. Joseph Buxbaum presents the first rat model for Shank3
“Growth factor improves autism symptoms in mice”
At the recent International Congress of Human Genetics in Montreal, Canada, Dr. Joseph Buxbaum presented findings indicating that insulin-like growth factor-1 (IGF-1) leads to improvements in brain functioning in mice lacking a copy of the Shank3 gene. In 2012, Dr. … Continue reading
Posted in News
Comments Off on “Growth factor improves autism symptoms in mice”
New Study on SHANK3
A new study shows that SHANK3 is also involved in Alzheimer’s disease and shows the important role Zinc plays in the function of SHANK3. To read the full text of this study, please click http://www.ncbi.nlm.nih.gov/pubmed/21939532. To view all posts, click … Continue reading
Posted in News
Comments Off on New Study on SHANK3
New York Times Letter to the Editor
The New York Times recently published an article about the transition into adulthood for people with ASD. The article details the experiences of one young man as he entered the work force. (Read the full article here: Autistic and Seeking … Continue reading
Posted in News
Comments Off on New York Times Letter to the Editor
Seaver Center Athletes
Congratulations to Alex Kolevzon, Clinical Director of the Seaver Autism Center, and Sandeep Soorya, (husband of Latha Soorya, Chief Psychologist of the Seaver Center), who placed 23rd in the Relay Team Division at the Nautica New York City Triathlon! Half … Continue reading
Posted in News
Comments Off on Seaver Center Athletes
Haploinsufficiency of SHANK3 Is Very Likely Cause of PMS Neurological Features
Researchers at the Cytogenetics Laboratory, Scientific Institute E. Medea in Bosisio Parini, Italy have completed a study using 22q13 deletions as a model for examining the mechanisms behind terminal deletions. This study confirms that the major neurological features of Phelan-McDermid … Continue reading
Posted in News
Comments Off on Haploinsufficiency of SHANK3 Is Very Likely Cause of PMS Neurological Features